-Amplyx Pharmaceuticals Announces Positive Preliminary Data from Ongoing Fosmanogepix Phase 2 Study in Candidemia

Press/Media: Press / Media

PeriodSep 17 2019

Media coverage

1

Media coverage

  • Title-Amplyx Pharmaceuticals Announces Positive Preliminary Data from Ongoing Fosmanogepix Phase 2 Study in Candidemia
    Media name/outletENP Newswire
    CountryUnited Kingdom
    Date9/17/19
    PersonsGEORGE THOMPSONIII